ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Xenotransplantation"

  • 2017 American Transplant Congress

    Ex-Vivo Mitomycin-C Exposure Reduced Immunogenicity and Prolonged Survival of Islets by Suppressing the Secretion of Multiple Chemotaxis Factors.

    N. Sato,1 T. Anazawa,2 A. Kenjyo,1 T. Kimura,1 R. Okada,1 T. Ishigame,1 Y. Kofunato,1 J. Watanabe,1 M. Muto,1 A. Nishimagi,1 M. Gotoh,1 S. Marubashi.1

    1Department of Surgery, Division of Hepato-Biliary-Pancreatic and Transplant, Fukushima Medical University, Fukushima, Japan; 2Department of Surgery, Graduate School of Midicine, Kyoto University, Kyoto, Japan

    Background. Strategies to reduce immunogenicity of islets, and to prevent activation of pro-inflammatory events are essential to successful islet engraftment. We previously demonstrated that ex-vivo…
  • 2017 American Transplant Congress

    Porcine Albumin Elaboration During Perfusion of Transgenic Porcine Livers with Human Blood.

    A. Cimeno,1 J. Powell,1 B. French,1 D. Ayares,2 A. Azimzadeh,1 R. Pierson III,1 R. Barth,1 J. LaMattina.

    1Department of Surgery, University of Maryland, School of Medicine, Baltimore, MD; 2Revivicor, Inc., Blacksburg, VA

    PurposeIn addition to immune barriers, molecular incompatibilities between species are predicted to limit pig liver survival in primate xenotransplantation models. How perfusion with human blood…
  • 2017 American Transplant Congress

    Xenogeneic Lung Transplantation: Identifying Transgenes and Supportive Drug Treatments to Achieve Long-Term Survival.

    L. Burdorf,1 C. Laird,1 N. O'Neill,1 T. Zhang,1 D. Parsell,1 I. Tatarov,1 A. Cimeno,2 S. Sendil,1 K. Thomas,1 C. Phelps,2 D. Ayares,2 A. Azimzadeh,1 R. Pierson III.1

    1Surgery, University of Maryland, Baltimore, MD; 2Revivicor, Inc., Blacksburg, VA

    Purpose: Recent progress in genetic engineering has facilitated generation of pigs expressing various multi-transgene and knock-out combinations. Which transgenes and what targeted drug treatments are…
  • 2017 American Transplant Congress

    Recognition of Islet Xenografts In Vivo by Non-Obese Diabetic (NOD) Insulin-Specific CD4 T Cells.

    R. Gill, W. Dale, M. Crawford.

    Surgery and Immunology, University of Colorado Denver, Aurora, CO

    Xenogeneic islet transplantation has been one ongoing goal for treating autoimmune Type 1 diabetes. Autoimmune diabetes involves a T cell response restricted to the host…
  • 2016 American Transplant Congress

    Long Term Heterotopic Cardiac Xenograft Survival from Donor Pigs with Six Gene Modifications.

    M. Mohiuddin,1 A. Singh,1 J. Chan,1 P. Corcoran,1 M. Thomas III,2 B. Lewis,2 D. Ayares,3 K. Horvath.1

    1CSRP, NHLBI/NIH, Bethesda, MD; 2DVR / RS, NIH, Bethesda, MD; 3Revivicor, Inc, Blacksburgh, VA.

    Introduction: We have recently reported pig xenograft survival of more than 2.5 years in a heterotopic cardiac xenograft model. Some of the animals exhibited local…
  • 2016 American Transplant Congress

    Human Leukocyte Antigen-E Expression on Porcine GalTKO.hCD46 Cells Improves Ex-Vivo Xenograft Survival and Attenuates Injury.

    C. Laird,1 N. Kubicki,1 L. Burdorf,1 T. Zhang,1 X. Chang,1 G. Braileanu,1 C. Phelps,2 D. Ayares,2 A. Azimzadeh,1 R. Pierson.1

    1University of Maryland School of Medicine, Baltimore, MD; 2Revivicor, Inc, Blacksburg, VA.

    Purpose:Lung xenografts are subject to injury mechanisms associated with the sequestration of human cells, including natural killer (NK) cells. To control NK cell associated injury,…
  • 2016 American Transplant Congress

    Long-Term Islet Xenograft Survival Requires Effective Control of Early Xenogeneic IL-17 Response and Late Xenogeneic IFN-γ Response.

    H. Kang,1 S. Wang,2 X. Zhang,3 A. Singh,5 L. Zhang,1 W. Suarez-Pinzon,5 S. Miller,4 B. Hering,5 X. Luo.1,3,4

    1Medicine, Northwestern University, Chicago, IL; 2Surgery, Tianjin Union Medical Center, Tianjin, China; 3Comprehensive Transplant Center, Northwestern University, Chicago, IL; 4Microbiology and Immunology, Northwestern University, Chicago, IL; 5Schulze Diabetes Institute, University of Minnesota, Minneapolis, MN.

    Introduction: Tolerance induction for xenogeneic islet transplant remains a challenge. We have previously shown that peri-transplant infusion of donor cells treated with 1-ethyl-3-(3'-dimethylaminopropyl)-carbodiimide (ECDI) is…
  • 2016 American Transplant Congress

    Successful Human-to-NonHuman Primate Pancreatic Islet Intraportal Xenotransplantation Using a Human Allo-Based Immunosuppression Regimen and Its Potential Pre-Clinical Application.

    J. McGarrigle,1 M. Bochenek,1 E. Marchese,1 A. Khan,1 D. Gutierrez,1,2 A. Mikalauskaite,1 B. McCracken,1 M. Reedy,1 M. Omami,1 C.-C. Yeh,1 M. Spaggiari,1 M. Nourmohammadzadeh,1,2 D. Isa,1 S. Ghani,1 L.-J. Wang,1 J. Mendoza-Elias,1,2 Y. Wang,1 J. Oberholzer.1,2

    1Surgery, University of Illinois at Chicago, Chicago; 2Bioengineering, University of Illinois at Chicago, Chicago.

    Intraportal pancreatic islet cell transplantation is a successful treatment for type-1 diabetes (T1DM) in humans. Unfortunately, the lack of donor pancreatic organs is a major…
  • 2016 American Transplant Congress

    Multiplex Profiling of Plasma Proteins After Xenogenic Lung Exposure.

    A. Azimzadeh,1 N. Cheng,1 X. Cheng,1 E. Schwartz,1 L. Burdorf,1 S. Dahi,1 N. Kubicki,1 D. Parsell,1 T. Zhang,1 D. Cooper,2 C. Phelps,3 D. Ayares,3 R. Pierson III.1

    1Univ. Of Maryland, Baltimore, MD; 2University of Pittsburgh, Pittsburgh, PN; 3Revivicor, Blacksburg, VA.

    Background: Porcine lungs exhibit injury by human blood and are only partially protected in GalTKO organs with additional human membrane cofactor protein (hCD46). Residual injury…
  • 2016 American Transplant Congress

    Human PDL1+ SLA-DR– Swine Vascular Endothelial Cells Suppress Pig-Human PBMC Xeno-MLR(Mixed Lymphocyte Reaction) by Inducing Human Regulatory IL-10+Tr1(Type 1 Regulatory T Cells) Subset for Suppression of Xenogeneic Reactions.

    Q. Shao, Q. Diag.

    The Department of Immunology, School of Medicine, Jiangsu University, Zhenjiang, Jiangsu Province, China.

    Type 1 regulatory T cells(Tr1) are active in transplantation tolerance. The Tr1 cells are inducible in our lab from human CD4 T cells (hCD4 T)…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences